Works by An, Young-Chul


Results: 1165
    1

    An open-label expanded access program of afatinib in EGFR tyrosine kinase inhibitor-naïve patients with locally advanced or metastatic non-small cell lung cancer harboring EGFR mutations.

    Published in:
    2021
    By:
    • Keunchil Park;
    • Jin-Soo Kim;
    • Joo-Hang Kim;
    • Young-Chul Kim;
    • Hoon-Gu Kim;
    • Eun Kyung Cho;
    • Jong-Youl Jin;
    • Miyoung Kim;
    • Märten, Angela;
    • Jin-Hyoung Kang;
    • Park, Keunchil;
    • Kim, Jin-Soo;
    • Kim, Joo-Hang;
    • Kim, Young-Chul;
    • Kim, Hoon-Gu;
    • Cho, Eun Kyung;
    • Jin, Jong-Youl;
    • Kim, Miyoung;
    • Kang, Jin-Hyoung
    Publication type:
    journal article
    2
    3

    Clinical Activity of Pan-HER Inhibitors Against HER2-Mutant Lung Adenocarcinoma.

    Published in:
    2018
    By:
    • In-Jae Oh;
    • Jae Young Hur;
    • Cheol-Kyu Park;
    • Young-Chul Kim;
    • Seung Joon Kim;
    • Min Ki Lee;
    • Hee Joung Kim;
    • Kye Young Lee;
    • Jae Cheol Lee;
    • Chang-Min Choi;
    • Oh, In-Jae;
    • Hur, Jae Young;
    • Park, Cheol-Kyu;
    • Kim, Young-Chul;
    • Kim, Seung Joon;
    • Lee, Min Ki;
    • Kim, Hee Joung;
    • Lee, Kye Young;
    • Lee, Jae Cheol;
    • Choi, Chang-Min
    Publication type:
    journal article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25

    Methylphenidate-osmotic-controlled release oral delivery system treatment reduces parenting stress in parents of children and adolescents with attention-deficit/hyperactivity disorder.

    Published in:
    Human Psychopharmacology: Clinical & Experimental, 2013, v. 28, n. 6, p. 600, doi. 10.1002/hup.2363
    By:
    • Hwang, Jun‐Won;
    • Kim, Bongseog;
    • Kim, Yeni;
    • Kim, Tae‐Ho;
    • Seo, Wan‐Seok;
    • Shin, Dong‐Won;
    • Woo, Young‐Jae;
    • Yoo, Heejeong;
    • Lee, Jeong‐Seop;
    • Lee, Jong‐Hun;
    • Lim, Myung‐Ho;
    • Chung, Young‐Chul;
    • Jung, Chul‐Ho;
    • Yoo, Hanik K.
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    33
    34
    35
    36
    37

    Efficacy and Safety of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease After 97 Weeks: A Phase 3 Randomized Clinical Trial.

    Published in:
    JAMA Neurology, 2023, v. 80, n. 6, p. 558, doi. 10.1001/jamaneurol.2023.0552
    By:
    • Kishnani, Priya S.;
    • Diaz-Manera, Jordi;
    • Toscano, Antonio;
    • Clemens, Paula R.;
    • Ladha, Shafeeq;
    • Berger, Kenneth I.;
    • Kushlaf, Hani;
    • Straub, Volker;
    • Carvalho, Gerson;
    • Mozaffar, Tahseen;
    • Roberts, Mark;
    • Attarian, Shahram;
    • Chien, Yin-Hsiu;
    • Choi, Young-Chul;
    • Day, John W.;
    • Erdem-Ozdamar, Sevim;
    • Illarioshkin, Sergey;
    • Goker-Alpan, Ozlem;
    • Kostera-Pruszczyk, Anna;
    • van der Ploeg, Ans T.
    Publication type:
    Article
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50

    Real-World Experience of Nivolumab in Non-small Cell Lung Cancer in Korea.

    Published in:
    Cancer Research & Treatment, 2020, v. 52, n. 4, p. 1112, doi. 10.4143/crt.2020.245
    By:
    • Sun Min Lim;
    • Sang-We Kim;
    • Byoung Chul Cho;
    • Jin Hyung Kang;
    • Myung-Ju Ahn;
    • Dong-Wan Kim;
    • Young-Chul Kim;
    • Jin Soo Lee;
    • Jong-Seok Lee;
    • Sung Yong Lee;
    • Keon Uk Park;
    • Ho Jung An;
    • Eun Kyung Cho;
    • Tae Won Jang;
    • Bong-Seog Kim;
    • Joo-Hang Kim;
    • Sung Sook Lee;
    • Im-II Na;
    • Seung Soo Yoo;
    • Ki Hyeong Lee
    Publication type:
    Article